Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ariyan

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Pigment Cell & Melanoma Research|February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsRuth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.
Plastic and Reconstructive Surgery. Global Open|June 16, 2020
Acral Lentiginous Melanoma: Do Surgical Approach and Sentinel Lymph Node Biopsy Matter?Marc E Walker, Gang Han, Kyle Gabrick, et al.
Plastic and Reconstructive Surgery. Global Open|December 23, 2021
Methods of Sentinel Lymph Node Identification in Auricular MelanomaSeth Noorbakhsh, Marianna Papageorge, Renee M Maina, et al.
Frontiers in Oncology|November 14, 2025
Use of imiquimod topical therapy for management of malignant melanoma positive marginsKatelyn Lewis, Sara Islam, David P Alper, et al.
Genome Research|June 4, 2009
Genome-wide screen of promoter methylation identifies novel markers in melanomaYasuo Koga, Mattia Pelizzola, Elaine Cheng, et al.
Journal for Immunotherapy of Cancer|March 27, 2020
Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanomaNicholas D Klemen, Melinda Wang, Jill C Rubinstein, et al.
The Yale Journal of Biology and Medicine|September 27, 2012
Integrated analysis of tumor samples sheds light on tumor heterogeneityFabio Parisi, Mariann Micsinai, Francesco Strino, et al.
Current Problems in Cancer|September 14, 2011
Melanoma brain metastases: is it time to reassess the bias?Jaclyn C Flanigan, Lucia B Jilaveanu, Mark Faries, et al.
The Journal of Investigative Dermatology|July 1, 2006
Rab33A: characterization, expression, and suppression by epigenetic modificationElaine Cheng, Sergio E Trombetta, Daniela Kovacs, et al.
Frontiers in Oncology|May 24, 2023
The role of imaging and sentinel lymph node biopsy in patients with T3b-T4b melanoma with clinically negative diseaseMarianna V Papageorge, Renee M Maina, Amber Loren O King, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Pigment Cell & Melanoma Research|February 13, 2010
PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cellsRuth Halaban, Wengeng Zhang, Antonella Bacchiocchi, et al.
Plastic and Reconstructive Surgery. Global Open|June 16, 2020
Acral Lentiginous Melanoma: Do Surgical Approach and Sentinel Lymph Node Biopsy Matter?Marc E Walker, Gang Han, Kyle Gabrick, et al.
Plastic and Reconstructive Surgery. Global Open|December 23, 2021
Methods of Sentinel Lymph Node Identification in Auricular MelanomaSeth Noorbakhsh, Marianna Papageorge, Renee M Maina, et al.
Frontiers in Oncology|November 14, 2025
Use of imiquimod topical therapy for management of malignant melanoma positive marginsKatelyn Lewis, Sara Islam, David P Alper, et al.
Genome Research|June 4, 2009
Genome-wide screen of promoter methylation identifies novel markers in melanomaYasuo Koga, Mattia Pelizzola, Elaine Cheng, et al.
Journal for Immunotherapy of Cancer|March 27, 2020
Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanomaNicholas D Klemen, Melinda Wang, Jill C Rubinstein, et al.
The Yale Journal of Biology and Medicine|September 27, 2012
Integrated analysis of tumor samples sheds light on tumor heterogeneityFabio Parisi, Mariann Micsinai, Francesco Strino, et al.
Current Problems in Cancer|September 14, 2011
Melanoma brain metastases: is it time to reassess the bias?Jaclyn C Flanigan, Lucia B Jilaveanu, Mark Faries, et al.
The Journal of Investigative Dermatology|July 1, 2006
Rab33A: characterization, expression, and suppression by epigenetic modificationElaine Cheng, Sergio E Trombetta, Daniela Kovacs, et al.
Frontiers in Oncology|May 24, 2023
The role of imaging and sentinel lymph node biopsy in patients with T3b-T4b melanoma with clinically negative diseaseMarianna V Papageorge, Renee M Maina, Amber Loren O King, et al.
Pageof 8